QHSLab Past Earnings Performance

Past criteria checks 0/6

QHSLab's earnings have been declining at an average annual rate of -66.4%, while the Medical Equipment industry saw earnings growing at 4.2% annually. Revenues have been growing at an average rate of 91.6% per year.

Key information

-66.4%

Earnings growth rate

-55.5%

EPS growth rate

Medical Equipment Industry Growth4.3%
Revenue growth rate91.6%
Return on equity-129.2%
Net Margin-59.6%
Last Earnings Update31 Mar 2022

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How QHSLab makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

BST:E1Z Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Mar 221-110
31 Dec 211-110
30 Sep 211-110
30 Jun 211010
31 Mar 210000
31 Dec 200000
30 Sep 200000
30 Jun 200000
31 Mar 200000
31 Dec 190000
30 Sep 190000
30 Jun 190000
31 Mar 190000
31 Dec 180000
30 Sep 180000
30 Jun 180000
31 Mar 180000
31 Dec 170000
30 Sep 170000
30 Jun 170000
31 Mar 170000
31 Dec 160000
30 Sep 160000
30 Jun 160-100
31 Mar 160-100
31 Dec 150-100

Quality Earnings: E1Z is currently unprofitable.

Growing Profit Margin: E1Z is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: E1Z is unprofitable, and losses have increased over the past 5 years at a rate of 66.4% per year.

Accelerating Growth: Unable to compare E1Z's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: E1Z is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (3.3%).


Return on Equity

High ROE: E1Z has a negative Return on Equity (-129.24%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies